ChromaDex Corporation (NASDAQ:CDXC) tinted gains of +4.43% (+0.16 points) to US$3.77. The volume of 0.18 Million shares climbed down over an trading activity of 303.33 Million shares. EPS ratio determined by looking at last 12 month figures is -0.45. Over the same time span, the stock marked US$7.24 as its best level and the lowest price reached was US$2.86. The corporation has a market cap of US$216.21 Million.
ChromaDex Corporation (NASDAQ:CDXC)’s earnings per share has been growing at a 0.9 percent rate over the past 5 year when average revenue increase was noted as 12.8 percent. The return on equity ratio or ROE stands at 0 percent while most common profitability ratio return on investment (ROI) was -30.2 percent. The company’s institutional ownership is monitored at 12 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 49.2 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 1 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 0 think it is Hold. Recently, analysts have updated the overall rating to 1.5. 1 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.
Crown Crafts, Inc. (NASDAQ:CRWS) is worth US$60.06 Million and has recently risen 4.42% to US$5.9. The latest exchange of 0.16 Million shares is below its average trading activity of 20.72 Million shares. The day began at US$0 but the price moved to US$5.9 at one point during the trading and finally capitulating to a session high of US$5.9. The stock tapped a 52-week high of US$8.05 while the mean 12-month price target for the shares is US$9.
Currently, the stock carries a price to earnings ratio of 15.65, a price to book ratio of 1.54, and a price to sales ratio of 0.93. For the past 5 years, the company’s revenue has grown -5%, while the company’s earnings per share has grown 1.4%. With an institutional ownership near 46.3%, it carries an earnings per share ratio of 0.38.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 0 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 1 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.